Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Jennifer Benselin"'
Autor:
Emma Culver, Eleanor Barnes, Michael Pavlides, Hamish Innes, Jennifer Benselin, William Irving, Kartikeya Khanna, DeLIVER Consortium
Publikováno v:
BMJ Open, Vol 14, Iss 10 (2024)
Introduction Hepatocellular carcinoma (HCC) is the fastest-rising and fourth most common cause of cancer death worldwide. Liver cirrhosis is the largest underlying risk factor for HCC. Therefore, patients with cirrhosis should have regular ultrasound
Externí odkaz:
https://doaj.org/article/8da10780bd694316bfac8b0747024ae6
Autor:
Hamish Innes, Hans Dieter Nischalke, Indra Neil Guha, Karl Heinz Weiss, Will Irving, Daniel Gotthardt, Eleanor Barnes, Janett Fischer, M. Azim Ansari, Jonas Rosendahl, Shang‐Kuan Lin, Astrid Marot, Vincent Pedergnana, Markus Casper, Jennifer Benselin, Frank Lammert, John McLauchlan, Philip L. Lutz, Victoria Hamill, Sebastian Mueller, Joanne R. Morling, Georg Semmler, Florian Eyer, Johann von Felden, Alexander Link, Arndt Vogel, Jens U. Marquardt, Stefan Sulk, Jonel Trebicka, Luca Valenti, Christian Datz, Thomas Reiberger, Clemens Schafmayer, Thomas Berg, Pierre Deltenre, Jochen Hampe, Felix Stickel, Stephan Buch
Publikováno v:
Hepatology Communications, Vol 6, Iss 5, Pp 1213-1226 (2022)
The host genetic background for hepatocellular carcinoma (HCC) is incompletely understood. We aimed to determine if four germline genetic polymorphisms, rs429358 in apolipoprotein E (APOE), rs2642438 in mitochondrial amidoxime reducing component 1 (M
Externí odkaz:
https://doaj.org/article/b9ad89289a29441c95f20c3bfffcbd53
Autor:
Hamish Innes, Peter Jepsen, Scott McDonald, John Dillon, Victoria Hamill, Alan Yeung, Jennifer Benselin, April Went, Andrew Fraser, Andrew Bathgate, M. Azim Ansari, Stephen T. Barclay, David Goldberg, Peter C. Hayes, Philip Johnson, Eleanor Barnes, William Irving, Sharon Hutchinson, Indra Neil Guha
Publikováno v:
JHEP Reports, Vol 3, Iss 6, Pp 100384- (2021)
Background & Aims: Hepatocellular carcinoma (HCC) prediction models can inform clinical decisions about HCC screening provided their predictions are robust. We conducted an external validation of 6 HCC prediction models for UK patients with cirrhosis
Externí odkaz:
https://doaj.org/article/776f0b9432e44ddca1f7bb8a8c5de874
Autor:
Victoria Hamill, Will Gelson, Douglas MacDonald, Paul Richardson, Stephen D. Ryder, Mark Aldersley, Stuart McPherson, Sumita Verma, Rohini Sharma, Sharon Hutchinson, Jennifer Benselin, Eleanor Barnes, Indra Neil Guha, William L. Irving, Hamish Innes
Funder: Cancer Research UK; Id: http://dx.doi.org/10.13039/501100000289
Funder: Medical Research Council
Funder: Medical Research Foundation
BACKGROUND: Previous studies show the uptake of biannual ultrasound (US) surveillance in patie
Funder: Medical Research Council
Funder: Medical Research Foundation
BACKGROUND: Previous studies show the uptake of biannual ultrasound (US) surveillance in patie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::68963dbba6402d071450a5dcd8691620
https://www.repository.cam.ac.uk/handle/1810/346671
https://www.repository.cam.ac.uk/handle/1810/346671
Autor:
E Barnes, Thomas Reiberger, Markus Casper, Jens U. Marquardt, Philipp Lutz, S Sulk, Hans Dieter Nischalke, Thomas Berg, Pierre Deltenre, John McLauchlan, Jonel Trebicka, Clemens Schafmayer, William L. Irving, Morling, Felix Stickel, V Hamill, Jochen Hampe, Daniel Gotthardt, Jonas Rosendahl, Stephan Buch, Janett Fischer, Jennifer Benselin, Karl-Heinz Weiss, J von Felden, Georg Semmler, Frank Lammert, Hamish Innes, Luca Valenti, Arndt Vogel, Christian Datz, Astrid Marot, Indra Neil Guha, V Pedergnana, Alexander Link, A. Ansari, Florian Eyer, S Müller
Publikováno v:
Viszeralmedizin 2021 Gemeinsame Jahrestagung Deutsche Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS), Sektion Endoskopie der DGVS, Deutsche Gesellschaft für Allgemein und Viszeralchirurgie (DGAV).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d66102c7af917efea9cb60574b95012d
https://doi.org/10.1055/s-0041-1733609
https://doi.org/10.1055/s-0041-1733609
Autor:
Ana da Silva Filipe, David F. Bibby, Elihu Aranday-Cortes, Emma Hudson, Jennifer Benselin, Phil Troke, Carmen F. Manso, Brendan Healy, Daniel Bradshaw, Anthony Brown, David A. Smith, Joshua B Singer, John McLauchlan, William L. Irving, Eleanor Barnes, Jean L. Mbisa, M. Azim Ansari, E. Thomson
Sustained viral response (SVR) rates for direct-acting antiviral (DAA) therapy for hepatitis C virus (HCV) infection routinely exceed 95%. However, a small number of patients require retreatment. Sofosbuvir, velpatasvir and voxilaprevir (SOF/VEL/VOX)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2552a93f122a0fcf33b2e6e4a440b82b
Autor:
Hamish Innes, Alex J. Walker, Jennifer Benselin, Jane I. Grove, Vincent Pedergnana, M. Azim Ansari, Shang-Kuan Lin, John McLauchlan, Sharon J. Hutchinson, Eleanor Barnes, William L. Irving, Indra Neil Guha
Publikováno v:
Clinical and translational gastroenterology
Clinical and translational gastroenterology, 2022, 13 (3), pp.e00462. ⟨10.14309/ctg.0000000000000462⟩
Clinical and translational gastroenterology, 2022, 13 (3), pp.e00462. ⟨10.14309/ctg.0000000000000462⟩
International audience; Introduction: Risk-stratifying patients with hepatitis C virus (HCV) cirrhosis according to medium-term prognosis will inform clinical decision-making. It is unclear which biomarkers/models are optimal for this purpose. We qua
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::529fdd85347bb05b3ed634cd00712fbe
https://pubmed.ncbi.nlm.nih.gov/35142723
https://pubmed.ncbi.nlm.nih.gov/35142723
Autor:
Victoria Hamill, Stanley Wong, Jennifer Benselin, Mel Krajden, Peter Hayes, David Mutimer, Amanda Yu, John Dillon, Will Gelson, Hector Velasquez, Philip Johnson, Stephen Barclay, Maria Alvarez, Hidenori Toyoda, Kosh Agarwal, Andrew Fraser, Sofia Bartlett, Mark Aldersley, Andrew Bathgate, Mawuena Binka, Paul Richardson, Joanne Morling, Stephen Ryder, Douglas Macdonald, Sharon Hutchinson, Eleanor Barnes, Neil Guha, William Irving, Naveed Janjua, Hamish Innes
Publikováno v:
Journal of Hepatology. 77:S17
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::af9d285b3f80a8ff14f3fb528bf248f5
https://doi.org/10.1016/s0168-8278(22)00451-2
https://doi.org/10.1016/s0168-8278(22)00451-2
Publikováno v:
Hepatology Communications
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=r3c4b2081b22::04138ff96d68302fe191a9c7f97ec28b
Autor:
Elihu Aranday-Cortes, Daniel Bradshaw, Anthony Brown, Carmen F. Manso, Brendan Healy, Eleanor Barnes, Jennifer Benselin, Ana da Silva Filipe, Josh Singer, Jean L. Mbisa, David F. Bibby, Emma Hudson, E. Thomson, Phil Troke, M. Azim Ansari, John McLauchlan, William L. Irving, David A. Smith
Sustained viral response (SVR) rates to first-line Direct Acting Antiviral (DAA) therapy for hepatitis C virus (HCV) infection routinely exceed 95%. However, a small number of patients require retreatment. Sofosbuvir, velpatasvir and voxilaprevir (SO
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4ba0b6aef7eb8f6a8718ff460a9462f8
https://doi.org/10.1101/2020.10.13.20211862
https://doi.org/10.1101/2020.10.13.20211862